Key Takeaways
Lululemon Athletica Inc. shares fell 0.2% after Texas Attorney General Ken Paxton launched an investigation into whether the apparel maker misled consumers about the presence of toxic “forever chemicals” in its products, challenging the company’s wellness-focused branding.
"I will not allow any corporation to sell harmful, toxic materials to consumers at a premium price under the guise of wellness and sustainability," Paxton said in a statement.
The investigation was announced Monday via a civil investigative demand, questioning the safety and health impacts of Lululemon's apparel. The company's stock dropped to $163.60 following the news, extending its year-to-date decline to 21.8% and its 12-month fall to 37.5%. The probe focuses on synthetic materials and chemical compounds that may be associated with endocrine disruption and other health issues.
The Texas probe creates significant brand risk for Lululemon, whose market identity is heavily reliant on claims of quality, health, and wellness. Beyond potential legal and financial penalties, the investigation could erode consumer trust and invite broader regulatory scrutiny across the apparel industry regarding the use of per- and polyfluoroalkyl substances (PFAS), commonly known as forever chemicals.
The investigation by Attorney General Paxton, who posted about the probe on social media, adds another headwind for the embattled athletic wear company. Lululemon has seen its stock value erode significantly over the past year amid growing competition and a shifting consumer landscape.
Emerging research has continued to raise questions about the health impacts of PFAS chemicals, which are used in a wide variety of consumer products for their water- and stain-resistant properties. The action against Lululemon could set a precedent for how apparel companies are held accountable for the materials used in their products, particularly those that market a health-conscious lifestyle.
Lululemon could not be immediately reached for comment on the investigation.
This article is for informational purposes only and does not constitute investment advice.
